Literature DB >> 19322616

Endotherapy for Barrett's esophagus with high-grade dysplasia and intramucosal carcinoma.

Drew B Schembre1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19322616     DOI： 10.1007/s11605-009-0862-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  49 in total

1.  Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma.

Authors:  J L Van Laethem; R Jagodzinski; M O Peny; M Cremer; J Devière
Journal:  Endoscopy       Date:  2001-03       Impact factor: 10.093

2.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

Review 3.  Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus.

Authors:  Herbert C Wolfsen
Journal:  J Clin Gastroenterol       Date:  2005-03       Impact factor: 3.062

4.  Cancer statistics, 2002.

Authors:  Ahmedin Jemal; Andrea Thomas; Taylor Murray; Michael Thun
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

5.  Primary care physician attitudes toward endoscopic screening for GERD symptoms and unsedated esophagoscopy.

Authors:  Vikram Boolchand; Ashley Faulx; Ananya Das; Stephen Zyzanski; Gerard Isenberg; Gregory Cooper; Michael V Sivak; Amitabh Chak
Journal:  Gastrointest Endosc       Date:  2006-02       Impact factor: 9.427

6.  Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features.

Authors:  Christianne J Buskens; Marinke Westerterp; Sjoerd M Lagarde; Jacques J G H M Bergman; Fiebo J W ten Kate; J Jan B van Lanschot
Journal:  Gastrointest Endosc       Date:  2004-11       Impact factor: 9.427

7.  Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study.

Authors:  Femke P Peters; Mohammed A Kara; Wilda D Rosmolen; Fiebo J W ten Kate; Kausilia K Krishnadath; J Jan B van Lanschot; Paul Fockens; Jacques J G H M Bergman
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

8.  Newly developed Barrett's esophagus after subtotal esophagectomy.

Authors:  D Franchimont; A Covas; C Brasseur; J-L Van Laethem; I El-Nakadi; J Devière
Journal:  Endoscopy       Date:  2003-10       Impact factor: 10.093

9.  Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome.

Authors:  Valerie A Williams; Thomas J Watson; Fernando A Herbella; Oliver Gellersen; Daniel Raymond; Carolyn Jones; Jeffrey H Peters
Journal:  J Gastrointest Surg       Date:  2007-10-02       Impact factor: 3.452

10.  Minimally invasive esophagectomy: outcomes in 222 patients.

Authors:  James D Luketich; Miguel Alvelo-Rivera; Percival O Buenaventura; Neil A Christie; James S McCaughan; Virginia R Litle; Philip R Schauer; John M Close; Hiran C Fernando
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969
View more
  2 in total

Review 1.  Surgical Treatment of High-Grade Dysplasia and Early Esophageal Cancer.

Authors:  Patrick J McLaren; James P Dolan
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

2.  Multidisciplinary treatment of T1a adenocarcinoma in Barrett's esophagus: contemporary comparison of endoscopic and surgical treatment in physiologically fit patients.

Authors:  Henner M Schmidt; Kamran Mohiuddin; Artur M Bodnar; Mustapha El Lakis; Stephen Kaplan; Shayan Irani; Ian Gan; Andrew Ross; Donald E Low
Journal:  Surg Endosc       Date:  2015-11-05       Impact factor: 4.584
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.